ABS Ventures
VC Fund
Waltham, United States
ABS Ventures is a VC fund in Waltham focused on Software and Enterprise Software. Formed in 1982, ABS Ventures is a Boston-based venture capital firm backed by leading global institutional investors. The firm works with exceptional management teams to build industry leading companies in the software, communications and healthcare sectors. ABS Ventures provides more than just capital. The team brings to bear its collectiveoperational and enterprise-building expertise as well as an extensive network of industry contacts. ABS Ventures works in partnership with management teams and believes that patience and a long term approach drive great performance.
- Total investments:
- 37
- Last investment:
- Lead investor:
- 30%
Last updated:
For AI agents: llms.txt
Industries ABS Ventures invests in
Stages ABS Ventures invests in
Countries ABS Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Bruns Grayson
|
|||
Susan Adams
|
|||
Investment Focus
Industry
- Software 15 (41%)
- Enterprise Software 5 (14%)
- SaaS 4 (11%)
- Health Care 4 (11%)
- Security 3 (8%)
Stage
- Series B 10 (27%)
- Series C 9 (24%)
- Funding Round 5 (14%)
- Series A 4 (11%)
- Series D 3 (8%)
Country
- United States 22 (59%)
- Canada 2 (5%)
- United Kingdom 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Bruns Grayson
Managing Partner
|
Managing Partner | Total investments: 5 | Find email | |
Bill Burgess
Managing Partner
|
Managing Partner | Total investments: 7 | Find email | |
|
Susan Adams
CFO
|
CFO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
ClickSquared
|
ClickSquared is the premier real time relationship marketing services provider of intelligent, multi-channel marketing solutions creating perfectly timed, personalized interactions across all online and off-line direct channels. Leveraging a team of marketing and technology experts and an on-demand marketing platform, ClickSquared develops andexecutes accountable acquisition, growth and loyalty programs to help build some of the world's best known brands. | $9M / Series C / Jan 09, 2012 | |
Zilliant
|
Zilliant, Inc. provides price optimization and price management software for manufacturing, distribution, high-tech, and industrial service companies. The company’s pricing software enables manufacturers and distributors to adopt an approach to price analysis, optimization, price list management, quoting, and negotiation. It offers ZilliantPrecision Pricing Suite (ZPPS), an enterprise software that combines price segmentation and price optimization science with analytics and process automation software for price management; ZPPS Analytics, which provides segment-specific metrics and KPIs to deliver a view of pricing performance and uncover opportunities to improve; ZPPS Price Optimization that produces price and deal envelope recommendations for various price segment; and ZPPS Price List Manager, which administers price lists and policies, as well as other price instruments, such as discount and markup schedules. The company also provides ZPPS Deal Manager and Deal Manager for Agreements, and ZPPS Price Campaign Manager that provides inline analytics and KPIs for scoring deals against peer group benchmarks and enforces corporate price policies; and ZPPS Pricing Information Manager, which manages product mix and selection in various deals. In addition, Zilliant, Inc. offers deployment strategy and planning, and implementation methodology, as well as Zilliant education services for business and technical users. The company has a strategic alliance with Advanous. Zilliant, Inc. was founded in 1999 and is headquartered in Austin, Texas. | $13.1M / Jul 19, 2010 | |
Melinta Therapeutics
|
Melinta Therapeutics is an antibiotics-focused company. The company’s mission is to discover, develop and commercialize urgently needed, groundbreaking antibiotics to overcome drug-resistant, life-threatening infections. The need for new therapies for drug-resistant infections is widely recognized as one of the most serious public health issuesfacing the world today. To meet this need, Melinta Therapeutics is rapidly progressing its late-stage investigational antibiotic, delafloxacin, which is currently in Phase 3 development for acute bacterial skin and skin structure infections (ABSSSI). In addition, Melinta is focused on its ongoing research program to develop a new class of antibiotics designed to overcome the resistant ESKAPE pathogens known to cause the majority of serious hospital infections and patient deaths. Melinta Therapeutics is privately held and backed by Vatera Healthcare Partners and Warburg Pincus. | $25M / Series D / Jan 25, 2009 | |
|
ClickSquared
|
ClickSquared is the premier real time relationship marketing services provider of intelligent, multi-channel marketing solutions creating perfectly timed, personalized interactions across all online and off-line direct channels. Leveraging a team of marketing and technology experts and an on-demand marketing platform, ClickSquared develops andexecutes accountable acquisition, growth and loyalty programs to help build some of the world's best known brands. | $11M / Series B / Jan 01, 2009 | |
Certona
|
Certona, the leading real-time omnichannel personalization solution and pioneer of AI-driven individualization, powers 73 billion unique experiences each month. Trusted by more than 600 brands in over 70 countries, Certona’s patented technology leverages machine learning and predictive analytics to deliver a fully-orchestrated experience withoptimized content and messaging to increase engagement and conversions across all customer touchpoints. | Series A / Jul 22, 2008 | |
Hanger Network In-Home Media
|
Hanger Network In-Home Media's EcoHanger Delivery Programs meet business and marketing needs. They are flexible, targeted and efficient. Their products serve the purposes of the client and also protect the environment. | Series B / Jun 01, 2008 | |
Persystent Technologies
|
Persystent offers a personal computer life cycle management solution that automates desktop and laptop availability and compliance. Their products serve the manufacturing, technology, healthcare, insurance, government, finance, and education industries. | $11.6M / Series C / Apr 17, 2008 | |
HighRoads
|
As a next generation health plan product management company, HighRoads envisions a world where plans deliver what their customers want with the touch of a button. A future that includes on-demand price and product customization at the point of sale. Where a fundamentally new go-to-market strategy transforms the competitive landscape, and our clientplans win. HighRoads’ sophisticated platform delivers an enterprise-wide single source of truth that streamlines product creation from concept to launch through process automation. Build new products in minutes instead of months by replacing manual processes, automatically incorporating changes in benefit data, and generating accurate member communications documents with the click of a button. | Series C / Apr 15, 2008 | |
ScaleMP
|
ScaleMPâ„¢ is the leader in virtualization for high-end computing, providing higher performance and lower Total Cost of Ownership (TCO). The innovative Versatile SMPâ„¢ (vSMP) architecture aggregates multiple x86 systems into a single virtual x86 system, delivering an industry-standard, high-end symmetric multiprocessor (SMP) computer. Usingsoftware to replace custom hardware and components, ScaleMP offers a new, revolutionary computing paradigm. | $8M / Apr 08, 2008 | |
Evalve
|
Evalve, Inc. engages in the design, development, manufacture, and marketing of devices that enable the repair of cardiac valves. It provides a non-surgical mitral valve repair system consisting of a steerable guide catheter, a clip delivery system, and an implant device that is used by interventional cardiologists to reduce mitral regurgitation.The company was incorporated in 1999 and is based in Menlo Park, California. | $60M / Series D / Nov 27, 2007 | |
| See all 37 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does ABS Ventures invest in?
ABS Ventures invests primarily in Software, Enterprise Software and SaaS startups, most often at Series B and Series C stage. Most of the 37 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact ABS Ventures?
Public channels for ABS Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at ABS Ventures?
The team at ABS Ventures includes Bruns Grayson (Managing Partner), Bill Burgess (Managing Partner) and Susan Adams (CFO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
